Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1945 18
1946 71
1947 95
1948 134
1949 138
1950 163
1951 252
1952 268
1953 332
1954 310
1955 341
1956 383
1957 417
1958 431
1959 413
1960 455
1961 468
1962 523
1963 775
1964 1054
1965 785
1966 729
1967 718
1968 799
1969 763
1970 774
1971 779
1972 847
1973 821
1974 835
1975 913
1976 918
1977 1061
1978 1076
1979 1235
1980 1307
1981 1202
1982 1446
1983 1541
1984 1638
1985 1606
1986 1768
1987 1713
1988 1902
1989 2097
1990 1971
1991 1942
1992 2108
1993 2119
1994 2154
1995 2200
1996 2378
1997 2322
1998 2494
1999 2483
2000 2636
2001 2655
2002 2773
2003 2982
2004 3112
2005 3278
2006 3423
2007 3605
2008 3993
2009 4122
2010 4489
2011 4887
2012 5254
2013 5421
2014 5881
2015 5919
2016 6059
2017 6182
2018 6171
2019 6481
2020 7130
2021 7245
2022 7057
2023 6556
2024 2016

Text availability

Article attribute

Article type

Publication date

Search Results

163,769 results

Results by year

Filters applied: . Clear all
Page 1
Amelanotic acrochordon.
S Pillai N, Buccha Y. S Pillai N, et al. BMJ Case Rep. 2024 Feb 23;17(2):e259515. doi: 10.1136/bcr-2023-259515. BMJ Case Rep. 2024. PMID: 38395467 No abstract available.
Prostataspezifisches Membranantigen (PSMA)-exprimierende Melanommetastasen bei einem Patienten mit Prostatakarzinom und Melanom: Prostate-specific membrane antigen (PSMA)-expressing melanoma metastases in a patient with prostate cancer and melanoma.
Hirsch J, Voltin CA, Schmiel M, Kreuzberg N, Mauch C, Franklin C. Hirsch J, et al. J Dtsch Dermatol Ges. 2024 Mar;22(3):446-449. doi: 10.1111/ddg.15323_g. J Dtsch Dermatol Ges. 2024. PMID: 38450949 German. No abstract available.
Melanoma crash course.
Ashton R, Wilkinson AN. Ashton R, et al. Can Fam Physician. 2024 Apr;70(4):254-257. doi: 10.46747/cfp.7004254. Can Fam Physician. 2024. PMID: 38627006 Free article. No abstract available.
[Spontaneous retroperitoneal hematoma].
Bakas JM, Kooiman AL, van Rijn MJE. Bakas JM, et al. Ned Tijdschr Geneeskd. 2024 Mar 19;168:D7726. Ned Tijdschr Geneeskd. 2024. PMID: 38546048 Dutch.
Overall Survival and Response with Nivolumab and Relatlimab in Advanced Melanoma.
Long GV, Stephen Hodi F, Lipson EJ, Schadendorf D, Ascierto PA, Matamala L, Salman P, Castillo Gutiérrez E, Rutkowski P, Gogas HJ, Lao CD, Janoski De Menezes J, Dalle S, Arance A, Grob JJ, Keidel S, Shaikh A, Sobiesk AM, Dolfi S, Tawbi HA. Long GV, et al. NEJM Evid. 2023 Apr;2(4):EVIDoa2200239. doi: 10.1056/EVIDoa2200239. Epub 2023 Mar 22. NEJM Evid. 2023. PMID: 38320023 Clinical Trial.
Immunotherapy for non-small cell lung cancer.
Kagamu H. Kagamu H. Respir Investig. 2024 Mar;62(2):307-312. doi: 10.1016/j.resinv.2024.01.011. Epub 2024 Feb 3. Respir Investig. 2024. PMID: 38310751 Review.
163,769 results
You have reached the last available page of results. Please see the User Guide for more information.